NOVADEL PHARMA INC·4

Jun 21, 4:56 PM ET

SCHAUL ROBERT F 4

4 · NOVADEL PHARMA INC · Filed Jun 21, 2004

Insider Transaction Report

Form 4
Period: 2004-05-21
Transactions
  • Award

    Stock Option

    [F2]
    2004-05-06+50,00050,000 total
    Exercise: $1.95Exp: 2009-04-18Common Stock (50,000 underlying)
Holdings
  • Common Stock

    39,286
  • Stock Option

    [F1]
    Exercise: $0.63Exp: 2006-07-31Common Stock (20,000 underlying)
    20,000
  • Stock Option

    [F1]
    Exercise: $0.63Exp: 2008-03-31Common Stock (25,000 underlying)
    25,000
  • Stock Option

    [F1]
    Exercise: $0.63Exp: 2009-09-30Common Stock (10,000 underlying)
    10,000
  • Stock Option

    [F1]
    Exercise: $0.63Exp: 2010-01-31Common Stock (95,000 underlying)
    95,000
  • Stock Option

    [F1]
    Exercise: $2.69Exp: 2012-02-14Common Stock (75,000 underlying)
    75,000
  • Stock Option

    [F1]
    Exercise: $1.51Exp: 2008-03-27Common Stock (10,000 underlying)
    10,000
Footnotes (2)
  • [F1]Information has been previously filed with the Securities and Exchange Commission.
  • [F2]The options vest in three annual installments. 16,666 options become exercisable on April 19, 2005, 16,666 become exercisable on April 19, 2006 and 16,667 become exercisable on April 19, 2007.
Signature
/s/ Robert F. Schaul|2004-05-21

Documents

1 file
  • 4
    v04115_4-schaulex.xmlPrimary